Experts are drawing on lessons learned from the early days of the HIV epidemic to address the current opioid epidemic. As a result of widespread opioid abuse, new epidemics of hepatitis C virus (HCV) and HIV infection have arisen and hospitalizations for related infections have increased. An expert panel convened by the National Academies of Sciences, Engineering, and Medicine (NASEM) recommends five crucial steps for clinicians treating patients affected by opioid addiction and these intersecting infections. The NASEM workshop proceedings will be published on July 13 and the action steps recommended by three of the planning committee members are published in Annals of Internal Medicine.
Optimal treatment of new epidemics of HCV, HIV, and other infections is often impeded by untreated opioid use disorder and few healthcare providers have the resources and expertise to handle these complex cases. As such, The Department of Health and Human Services (HHS) requested the NASEM convene a workshop where a panel of experts could outline action steps for addressing the intersecting epidemics of opioid use disorder and its infectious disease consequences.
The experts identified parallels between the current opioid epidemic and the early days of the HIV epidemic. Care of HIV-infected patients benefited greatly from the development of a highly trained interdisciplinary workforce partnering across treatment settings and specialties. With these lessons in mind, the panelists agreed upon five action steps for clinicians. Included in the action steps are recommendations for increasing access to addiction care and funding to states to provide effective medications to treat OUD. The experts also recommend the development of hospital-based protocols to link patients directly to community-based treatment upon discharge from the hospital.
Source: American College of Physicians
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.